Statistics

Sanjing net profit up 12.5% in Q3

(Xinhua)
Updated: 2009-10-19 15:36

Harbin Pharm Group Sanjing Pharmaceutical Co Ltd, one of China's leading pharmaceutical manufacturers, announced Sunday that its net profit in the third quarter rose 12.49 percent year-on-year to 80.1 million yuan ($11.7 million).

Related readings:
Sanjing net profit up 12.5% in Q3 Pharmaceutical giants eye China's booming market
Sanjing net profit up 12.5% in Q3 Pharmaceutical shares lose luster
Sanjing net profit up 12.5% in Q3 French drugmaker to produce anti-diabetes drug in China
Sanjing net profit up 12.5% in Q3 Pharma health means more jobs

Total assets of the northeastern Heilongjiang-based firm increased 9.3 percent year-on-year to 3.19 billion yuan, it said in a statement to the Shanghai Stock Exchange.

The company attributed the net profit rise to its sound business operating situation and reduced inventory.

The equities of the Shanghai-listed firm ended at 17.71 yuan per share on Friday, up 1.78 percent from the previous close.
Specials
Columnists
China Daily E-paper